Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

284
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
284
Lipid Digestion01:06

Lipid Digestion

98.3K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
98.3K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

481
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
481
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

6.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal consumption of Bertholletia excelsa oil modulates reflex maturation and memory in rat offspring.

Neuroscience·2026
Same author

Maternal Intake of Dipteryx alata Vog. Reduces Offspring's Brain Oxidative Stress and Anxiety: Insights From In Silico and In Vivo Studies.

Journal of food science·2026
Same author

Quality Characteristics of Processed Opuntia ficus-indica Using Selected Drying Techniques.

Journal of food science·2026
Same author

Opuntia ficus-indica Flour Modulates Fecal Microbiota, Reduces Cerebral Oxidative Stress and Improves Cognitive Function in Elderly Rats.

Plant foods for human nutrition (Dordrecht, Netherlands)·2026
Same author

Chemical Screening, Botanical Origin, and Antioxidant Potential of Apis Mellifera Honeys From the Brazilian Caatinga Biome.

Chemistry & biodiversity·2026
Same author

Investigating the behavioral impact of tropical almond (Terminalia catappa L.) consumption: Anxiolytic effects and memory preservation in aged rats.

Experimental neurology·2026

Related Experiment Video

Updated: Jan 2, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.6K

Cashew nuts (Anacardium occidentale L.) decrease visceral fat, yet augment glucose in dyslipidemic rats.

Celina C Q Dias1, Marta S Madruga1, Maria Manuela E Pintado2

  • 1DEA-Department of Food Engineering, Technology Centre, Federal University of Paraiba, João Pessoa, Paraiba, Brazil.

Plos One
|December 13, 2019
PubMed
Summary
This summary is machine-generated.

Roasted cashew nut consumption in dyslipidemic rats worsened glycemic levels and increased liver fat accumulation. However, it reduced visceral fat and increased fecal fat excretion, indicating complex metabolic effects.

More Related Videos

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet
13:09

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet

Published on: July 31, 2021

4.0K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.5K

Related Experiment Videos

Last Updated: Jan 2, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.6K
Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet
13:09

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet

Published on: July 31, 2021

4.0K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.5K

Area of Science:

  • Nutritional biochemistry
  • Animal models of dyslipidemia

Background:

  • Dyslipidemia is a metabolic disorder characterized by abnormal lipid levels.
  • Dietary interventions are crucial for managing dyslipidemia.
  • Cashew nuts possess unique nutritional properties that warrant investigation in metabolic health.

Purpose of the Study:

  • To investigate the biological effects of roasted cashew nuts on biochemical and murinometric parameters in dyslipidemic rats.
  • To assess the impact of cashew nut consumption on lipid profiles, glycemic control, and fat distribution in a hyperlipidemic model.

Main Methods:

  • Randomized assignment of young male rats into Control, Dyslipidemic (DL), and Dyslipidemic Cashew Nuts (DLCN) groups.
  • Administration of a high-fat emulsion to DL and DLCN groups, with DLCN receiving roasted cashew nuts.
  • Evaluation of body parameters, biochemical markers, and hepatic and fecal fatty acid profiles.

Main Results:

  • Both DL and DLCN groups showed elevated total cholesterol and triglycerides compared to controls.
  • DLCN exhibited higher glycemia levels and increased liver fat accumulation, despite reduced visceral fat.
  • Cashew nut consumption led to changes in hepatic fatty acid profiles, including reduced saturated fatty acids and increased omega-9 fatty acids, and lower fecal polyunsaturated fatty acids.

Conclusions:

  • Roasted cashew nut consumption in a hyperlipidemic rat model exacerbated liver fat accumulation and worsened glycemic control.
  • Despite adverse effects on liver and glucose, cashew nuts reduced visceral fat and increased fecal fat excretion.
  • The findings suggest a complex interplay between cashew nut components and lipid metabolism in dyslipidemia.